Riskpilot← Back to searchSign inGet full accessSuomen Bioanalytiikka Oy
OYActiveY-tunnus 1065417-1Riihiraitti 5Technical testing and analysis · NACE 7120Est. 19960 employees
Revenue 2024
EUR 127K
+3% vs 2023
EBITDA margin
64.5%
+4% vs 2023
Equity ratio
98.0%
Financial strength
Net profit 2024
EUR 98K
0% vs 2023
| Revenue | EUR 127K | +3% |
| EBITDA | EUR 82K | +4% |
| Net profit | EUR 98K | +0% |
| Total assets | EUR 971K | — |
| Equity | EUR 952K | +11% |
| Employees | 0 | — |
Legal name
Suomen Bioanalytiikka Oy
Y-tunnus number
1065417-1
Legal form
Osakeyhtiö
NACE code
7120 · Technical testing and analysis
Founded
4. lokakuuta 1996
Share capital
EUR 83 034
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Yhtiön toimiala on harjoittaa bioanalyyttistä tutkimusta ja laboratoriopalvelujen myyntiä, bioanalyysilaitteiden, -tarvikkeiden ja menetelmien kehitystä, valmistusta ja myyntiä. Yhtiö voi harjoittaa bioanalyyttisten tuotteiden maahantuontia, vientiä ja myyntiä. Yhtiö voi harjoittaa myös alaan liittyvää konsultointia, koulutusta ja agentuuritoimintaa. Yhtiö voi omistaa kiinteistöjä ja harjoittaa arvopaperikauppaa.
Address
Riihiraitti 5
Phone
+358456342038
Email
timo.rissanen@forandi.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 106 | 81 | 101 | 124 | 127 |
| Staff expenses | −20 | −14 | −20 | −18 | −17 |
| EBITDA | 59 | 44 | 54 | 79 | 82 |
| Depreciation & amort. | — | — | — | −0 | −0 |
| EBIT | 59 | 44 | 54 | 79 | 82 |
| Net financials | 8 | 9 | 10 | 42 | 40 |
| Profit before tax | 68 | 53 | 64 | 121 | 122 |
| Tax | 14 | 9 | 13 | −0 | 25 |
| Net profit | 54 | 44 | 51 | 97 | 98 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 621 | 662 | 714 | 0 | 971 |
| Equity | 611 | 655 | 706 | 854 | 952 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 10 | 7 | 7 | 22 | 20 |
| Total debt | 10 | 7 | 7 | 22 | 20 |
EBITDA margin
64.5%
This company
15.8%
Market median
+308% vs market
20202024
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
76.8%
This company
8.1%
Market median
+848% vs market
20202024
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Deputy auditor | Deputy auditor | 2007 |
MV | Audit | 2020 |
| Former (1) | ||
TJ Audit | Audit | 2007 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairperson | 2024 | |
| Board of Directors | 2020 | |
| Former (4) | ||
| Board of Directors | 2018 – 2020 | |
| Chairperson | 2024 – 2024 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2018 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Suomen Bioanalytiikka Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simo Juhani Ilmari Salonen | Deputy auditor | 0 companies |
| Mikko Valtteri Lumila | Audit | 0 companies |
| Teppo Johannes Aro | Audit | 0 companies |
| Paul James Martin | Board of Directors | 0 companies |
| John Leo Healy | Board of Directors | 0 companies |
| Michael Simon Schütz | Chairperson | 0 companies |
| Nicola Mitton | Board of Directors | 0 companies |
| Dirk Beecker | Chairperson | 0 companies |
| Juha Tapani Saarela | Board of Directors | 0 companies |
| Timo Tapani Rissanen | Board of Directors | 0 companies |